PSA: Clinical Trials

19 trials for PSA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 4 completed, 3 active not recruiting, 3 recruiting. 8 Not applicable, 2 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 4, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 22Active not recruiting 1, Terminated 1
Phase 41Recruiting 1

Follow PSA: new trials by email Literature Review of PSA trials Research Report on PSA

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of Electroacupuncture at Xuanzhong (GB39) and Tongli (HT5) Points in Post-Stroke Aphasia
Electroacupuncture, Basic treatment + Speech therapy, Sham Electroacupuncture - Post-stroke Aphasia, PSA
Not applicableNot yet recruitingUniversity of Medicine and Pharmacy at Ho Chi Minh City302026-07-012026-07-06
MRI-Assisted Guidance for Non-Essential Tissue Sampling
Paired Prostate Biopsy Cohort (TB + SB) - PSA Progression, PSA
Not applicableRecruitingShanghai East Hospital12352026-04-052026-06-24
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
Ibuprofen 400 mg, TID, PSA test - Prostate Cancer, Prostate Inflammation
Phase 4RecruitingAlbany Medical College1982022-09-272024-10-18
Therapeutic Study of Prostatitis With Elevated PSA
Huange capsule - Prostatitis, PSA
Not applicableUnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine602022-08-012023-02-17
Retrospective Chart Review of Treataprost Added to Antibiotic Treatment in Patients With Chronic Prostatitis
TREATAPROST - Quality of Life, Infection, Bacterial
UnknownGMG Grand Medical1402022-04-152022-04-01
Smart Prostate Specific Antigen (PSA) Screening Study
Completing surveys - PSA, Prostate Cancer
Not applicableCompletedUniversity of Illinois at Chicago492021-12-172026-01-22
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
Darolutamide, Radiotherapy - Advanced Prostate Carcinoma, Cancer of Prostate
Phase 2Active not recruitingTrans Tasman Radiation Oncology Group652021-06-022025-08-21
PSA Glycomics Assay for Early Detection of Prostate Cancer
PSA Glycomics Assay - Prostate Cancer, PSA
Not applicableUnknownProf.dr. H.P. Beerlage1502020-08-012023-09-26
Marker Driven Selection of Patients for Prostate Biopsy and Management
PSA, Elevated PSA
Active not recruitingUniversity of Miami2892020-06-292026-06-12
RegisterPROS - A Registry for Prostate Cancers
PROSTest - Prostate Cancer (Adenocarcinoma), Prostate Biopsy
Enrolling by invitationWren Laboratories LLC10002020-01-152026-08-21
Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV
p2PSA, Ultrasonic parameters, Transperineal prostate biopsy - Prostate Cancer, PSA
UnknownXinhua Hospital, Shanghai Jiao Tong University School of Medicine802020-01-042022-05-06
Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications
Systematic Transrectal biopsy (TR-Bx), Targeted Transrectal biopsy (TR-Bx), Systematic Transperineal biopsy (TP-Bx) - Prostate Cancer, PSA
Not applicableCompletedAlbany Medical College8402019-09-022025-12-23
EDRN Prostate MRI Biomarker Study
MRI prostate - PSA, Prostate Cancer
RecruitingUniversity of Michigan9502019-02-042026-08-17
MRI Prostate for Chinese Men Being Screened for Prostate Cancer
MRI prostate - Prostate Cancer, PSA
Active not recruitingChinese University of Hong Kong6902019-01-192024-11-22
Prostate Impendance Test Project
Prostatic Neoplasms, PSA
UnknownUniversity of Pisa1002017-07-012018-02-19
Promoting CSD500 Use Among Women in Established Relationships
CSD500 Condom, Standard Condom, Condom Counseling - PSA, Unprotected Sex
Not applicableCompletedOhio State University10002017-06-092024-12-13
Altered PSA Test Due to Possible Suspected Heterophilic Antibodies
PSA
TerminatedUniversity of Zurich502015-03-012017-05-31
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
OGX-427, Abiraterone Acetate, Prednisone - Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer
Phase 2TerminatedCostantine Albany722012-12-012022-07-11
Closing the Gap in Care in Seronegative Inflammatory Arthritis
Education and Feedback - SpA, PsA
Not applicableCompletedPope Research Corporation402012-11-012017-04-07

Narrower conditions

Prostatic Neoplasms (12)  ·  Prostatitis (3)  ·  Adenocarcinoma (1)  ·  Bacterial Infections (1)  ·  Communication Disorders (1)  ·  Hemorrhage (1)  ·  Infections (1)  ·  Salivary Gland Adenoma, Pleomorphic (1)  ·  Sexually Transmitted Diseases (1)  ·  Unsafe Sex (1)

Broader conditions

Genital Diseases (15)  ·  Urogenital Diseases (15)  ·  Genital Diseases, Male (14)  ·  Male Urogenital Diseases (14)  ·  Prostatic Diseases (14)  ·  Genital Neoplasms, Male (12)  ·  Neoplasms (12)  ·  Neoplasms by Site (12)  ·  Urogenital Neoplasms (12)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Infections (2)  ·  Pathologic Processes (2)  ·  Bacterial Infections and Mycoses (1)  ·  Behavior (1)  ·  Carcinoma (1)

Interventions

Abiraterone Acetate (1)  ·  Educational Status (1)  ·  Electroacupuncture (1)  ·  Ibuprofen (1)  ·  Prednisone (1)  ·  Radiotherapy (1)  ·  Speech Therapy (1)  ·  Urination (1)  ·  apatorsen (1)  ·  darolutamide (1)

Sponsors

Albany Medical College (2)  ·  Chinese University of Hong Kong (1)  ·  Costantine Albany (1)  ·  GMG Grand Medical (1)  ·  Ohio State University (1)  ·  Pope Research Corporation (1)  ·  Prof.dr. H.P. Beerlage (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Shanghai East Hospital (1)  ·  Trans Tasman Radiation Oncology Group (1)  ·  University of Illinois at Chicago (1)  ·  University of Medicine and Pharmacy at Ho Chi Minh City (1)  ·  University of Miami (1)  ·  University of Michigan (1)  ·  University of Pisa (1)

Countries

United States (6)  ·  China (3)  ·  Canada (2)  ·  Vietnam (2)  ·  Australia (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Abdel Halim, PhD, PharmD (1)  ·  Arun Azad (1)  ·  Badar M Mian, MD (1)  ·  Badar Mian, MD (1)  ·  Cabir Alan, Prof. Dr. (1)  ·  Constantine Albany, M.D. (1)  ·  Janet E Pope, MD, MPH, FRCPC (1)  ·  Jay Raman, MD (1)  ·  John Casterline, PhD (1)  ·  John T Wei, MD, MS (1)  ·  Kambiz Rahbar, MD (1)  ·  Marcia Hobbs, PhD (1)  ·  Maria Gallo, PhD (1)

Results publications

PMID 10422990, PMID 10584615, PMID 10604689, PMID 11061888, PMID 11176483, PMID 11679032, PMID 11932878, PMID 12131316, PMID 12410746, PMID 12712363, PMID 1425844, PMID 14550427, PMID 15197050, PMID 15643213, PMID 16122891, PMID 16286098, PMID 16409145, PMID 16454210, PMID 16635963, PMID 17509285, PMID 17706722, PMID 18538692, PMID 18597833, PMID 19467069, PMID 19748608, PMID 20633688, PMID 21420124, PMID 22899994, PMID 23194959, PMID 23195942, PMID 23436427, PMID 24914718, PMID 25032777, PMID 25613154, PMID 25621100, PMID 26050020, PMID 26926407, PMID 28813783, PMID 29498647, PMID 30271757, PMID 32294397, PMID 35176037, PMID 35463344, PMID 38700844, PMID 38847318, PMID 40640763, PMID 41761486, PMID 7206060, PMID 9338729

NIH funding

U01CA239141 (1)